InsiderTrades.com logo
liberals FOOLED by Elon’s shocking surprise
From StocksToTrade   |   Ad
Elon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the liberals broke”... But it turns out that was all just a smokescreen to hide the TRUTH…
Click here to discover the real reason Elon Musk became buddy-buddy with Trump.

RGT Insider Trading

Insider Ownership Percentage: 9.78%
Insider Buying (Last 12 Months): A$2,143,400.00
Insider Selling (Last 12 Months): A$0.00

Argent BioPharma Insider Trading History Chart

This chart shows the insider buying and selling history at Argent BioPharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Argent BioPharma Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 04/3/2024 01:04 PM ET

This chart shows the closing price history over time for RGT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
liberals FOOLED by Elon’s shocking surprise
From StocksToTrade   |   Ad
Elon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the liberals broke”... But it turns out that was all just a smokescreen to hide the TRUTH…
Click here to discover the real reason Elon Musk became buddy-buddy with Trump.

Argent BioPharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/15/2024Roby ZomerInsiderBuy4,000,000A$0.41A$1,640,000.00
9/10/2024Roby ZomerInsiderBuy1,258,500A$0.40A$503,400.00
See Full Table
liberals FOOLED by Elon’s shocking surprise
From StocksToTrade   |   Ad
Elon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the liberals broke”... But it turns out that was all just a smokescreen to hide the TRUTH…
Click here to discover the real reason Elon Musk became buddy-buddy with Trump.

SEC Filings (Institutional Ownership Changes) for Argent BioPharma (ASX:RGT)

1.10% of Argent BioPharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Argent BioPharma Limited, a drug discovery clinical-stage biopharmaceutical company, provides medicines targeting immunology and neurology worldwide. Its principal product candidates include CimetrA, which is in phase II clinical trial for the treatment of SLE Lupus, anti-inflammatory, and SARS COVID-19; and CannEpil, which is in phase I clinical trial for refractory epilepsy and cerebral palsy; and CogniCann, which is in phase I clinical trial for the symptomatic relief of Dementia and Alzheimer. In addition, the company provides Irnican for brain cancer. The company was formerly known as MGC Pharmaceuticals Limited and changed it name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.
Read More on Argent BioPharma

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05

Who are the company insiders with the largest holdings of Argent BioPharma?

Argent BioPharma's top insider shareholders include:
  1. Roby Zomer (Insider)
Learn More about top insider investors at Argent BioPharma.
liberals FOOLED by Elon’s shocking surprise
From StocksToTrade   |   Ad
Elon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the liberals broke”... But it turns out that was all just a smokescreen to hide the TRUTH…
Click here to discover the real reason Elon Musk became buddy-buddy with Trump.